tykhr
sign in
free sign up
Tvardi Therapeutics, Inc.
Biotechnology
Healthcare
TVRD
9.36 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
37.73
52 week high
39.04
high
38.92
52 week low
0.00
low
35.86
growth
244.62 %
previous Close
37.40
P/E ratio
market cap
div yield
0
usd
Mar 2025
qoq
revenue
2.57 M
0.00 %
net incoming
-4.91 M
0.00 %
eps
0.00 %
90.08 %
eps surprise
13.79 %
net profit margin
-190.97 %
-190.00 %
operating incoming
-2.39 M
0.00 %
net change in cash
-3.69 M
0.00 %
cash on hand
34.22 M
0.00 %
cost of revenue
0.00 %
top